<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Antidotes Chelating agents Iron metabolism Anemias Transfusion hemosiderosis Deferiprone Beta-thalassemia Iron overload Myelodysplastic syndrome Medicine Chemistry Health |
| Alternative strategies of iron chelation therapyDocID: 17AUG - View Document |
| DOCX DocumentDocID: 15O8X - View Document |
| PDF DocumentDocID: 15tBH - View Document |
| Microsoft Word - hs0624cb2[removed]e.docDocID: ZcZN - View Document |
| Contains Nonbinding Recommendations Draft Guidance on Deferiprone This draft guidance, once finalized, will represent the Food and Drug Administration’s (FDA’s) current thinking on this topic. It does not create orDocID: VoB0 - View Document |